Jane Street
RCUS icon

Jane Street’s Arcus Biosciences RCUS Stock Holding History

Jane Street’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-107,979
Closed -$2.67M – 12859
2026
Q1 		$2.33M Buy
107,979
+61,474
+132% +$1.33M ﹤0.01% 4794
2025
Q4 		$1.11M Sell
46,505
-179,127
-79% -$3.65M ﹤0.01% 5909
2025
Q3 		$3.07M Sell
225,632
-256,457
-53% -$2.67M ﹤0.01% 4177
2025
Q2 		$3.92M Buy
482,089
+377,487
+361% +$3.22M ﹤0.01% 3346
2025
Q1 		$821K Sell
104,602
-97,898
-48% -$1.14M ﹤0.01% 5938
2024
Q4 		$3.02M Sell
202,500
-14,541
-7% -$237K ﹤0.01% 3433
2024
Q3 		$3.32M Buy
217,041
+81,193
+60% +$1.28M ﹤0.01% 3536
2024
Q2 		$2.07M Buy
135,848
+60,939
+81% +$984K ﹤0.01% 4412
2024
Q1 		$1.41M Sell
74,909
-256,581
-77% -$4.44M ﹤0.01% 4764
2023
Q4 		$6.33M Buy
331,490
+220,191
+198% +$3.52M ﹤0.01% 2531
2023
Q3 		$2M Sell
111,299
-177,110
-61% -$3.56M ﹤0.01% 4059
2023
Q2 		$5.86M Buy
288,409
+252,847
+711% +$4.81M ﹤0.01% 2524
2023
Q1 		$649K Buy
35,562
+9,698
+37% +$185K ﹤0.01% 5864
2022
Q4 		$535K Sell
25,864
-7,967
-24% -$219K ﹤0.01% 6013
2022
Q3 		$885K Buy
33,831
+21,725
+179% +$575K ﹤0.01% 5630
2022
Q2 		$307K Sell
12,106
-12,755
-51% -$312K ﹤0.01% 7577
2022
Q1 		$785K Buy
+24,861
New +$833K ﹤0.01% 6625
2021
Q4 		– Sell
-22,515
Closed -$873K – 10691
2021
Q3 		$786K Buy
+22,515
New +$701K ﹤0.01% 6401
2021
Q2 		– Sell
-19,997
Closed -$562K – 10299
2021
Q1 		$562K Buy
19,997
+11,194
+127% +$390K ﹤0.01% 6583
2020
Q4 		$228K Sell
8,803
-6,107
-41% -$148K ﹤0.01% 6785
2020
Q3 		$256K Sell
14,910
-8,345
-36% -$186K ﹤0.01% 6105
2020
Q2 		$575K Buy
+23,255
New +$628K ﹤0.01% 4862
2019
Q1 		– Sell
-29,957
Closed -$323K – 5513
2018
Q4 		$323K Buy
+29,957
New +$350K ﹤0.01% 3981

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Jane Street's RCUS Position: Q2 2026 in Review

Jane Street sold out of Arcus Biosciences (RCUS) in Q2 2026, closing a stake of 107,979 shares — an estimated $2.67M sold.

Jane Street first reported a position in RCUS in Q4 2018 and held it in 23 quarters. The position peaked at $6.33M in Q4 2023. 232 funds tracked by Wall St. Rank hold RCUS as of Q2 2026.

  • Jane Street reported no remaining Arcus Biosciences position as of Q2 2026 after selling out during the quarter.
  • Jane Street sold 107,979 Arcus Biosciences shares in Q2 2026, an estimated $2.67M.
  • Jane Street first reported a position in Arcus Biosciences in Q4 2018 and held it in 23 quarters.
  • Jane Street's Arcus Biosciences position peaked at $6.33M in Q4 2023.
  • 232 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.